↓ Skip to main content

Prognostic factors and disease‐specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden

Overview of attention for article published in International Journal of Cancer, April 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prognostic factors and disease‐specific survival among immigrants diagnosed with cutaneous malignant melanoma in Sweden
Published in
International Journal of Cancer, April 2016
DOI 10.1002/ijc.30103
Pubmed ID
Authors

Caroline Simberg-Danell, Johan Lyth, Eva Månsson-Brahme, Margareta Frohm-Nilsson, John Carstensen, Johan Hansson, Hanna Eriksson

Abstract

Little is known about cutaneous malignant melanoma (CMM) among immigrants in Europe. We aimed to investigate clinical characteristics and disease-specific survival among first- and second-generation immigrants in Sweden This nationwide population-based study included 27,235 patients from the Swedish Melanoma Register diagnosed with primary invasive CMM 1990-2007. Data were linked to nationwide, population-based registers followed up through 2013. Logistic regression and Cox regression models were used to determine the association between immigrant status and stage and CMM prognosis, respectively. stage. After adjustments for confounders, first generation immigrant from Southern Europe were associated with significantly more advanced stages of disease compared to Swedish-born patients (Stage II vs I: Odds ratio (OR)=2.37, 95% CI=1.61 to 3.50. Stage III-IV vs I: OR=2.40, 95% CI = 1.08-5.37). stageThe ORsof stage II-IV vs stage I disease were increased among men (OR=1.9; 95% CI=1.1 - 3.3; P=0.020), and inwomen (OR=4.8; 95% CI=2.6 - 9.1; P < 0.001) in a subgroup of immigrants from former Yugoslavia compared to Swedish-born patients. In conclusion, the CMM-specific survival was significantly decreased among women from former Yugoslavia compared to Swedish-born women (hazard ratio (HR) = 2.2; 95% CI=1.1 - 4.2; P=0.043). After additional adjustment including stage, the survival difference was no longer significant. No survival difference between the second generation immigrant group and Swedish-born patients were observed. A worse CMM-specific survival in women from former Yugoslavia was associated with more advanced stages of CMM at diagnosis. Secondary prevention efforts focusing on specific groups may be needed to further improve CMM prognosis. This article is protected by copyright. All rights reserved.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 19%
Student > Bachelor 4 15%
Student > Ph. D. Student 2 8%
Student > Postgraduate 2 8%
Student > Master 2 8%
Other 4 15%
Unknown 7 27%
Readers by discipline Count As %
Medicine and Dentistry 10 38%
Biochemistry, Genetics and Molecular Biology 4 15%
Psychology 2 8%
Agricultural and Biological Sciences 1 4%
Nursing and Health Professions 1 4%
Other 1 4%
Unknown 7 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2019.
All research outputs
#8,534,528
of 25,371,288 outputs
Outputs from International Journal of Cancer
#5,016
of 12,204 outputs
Outputs of similar age
#114,245
of 313,412 outputs
Outputs of similar age from International Journal of Cancer
#50
of 99 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,204 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 24th percentile – i.e., 24% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 313,412 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 99 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.